Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa

Conditions:   Tuberculosis;   HIV I Infection;   Sepsis Interventions:   Other: Immediate anti-TB therapy;   Other: Sepsis-specific dose anti-TB therapy Sponsors:   University of Virginia;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials